MENU
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ultragenyx Pharmaceutical (RARE) Ownership - Who owns Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.37B
P/E Ratio
N/A
Total Cash
610.03M
Projected Growth
N/A
Total Debt
40.34M
Revenue
560.23M
Risk (Beta)
0.04
Dividend Yield
N/A
Total Cash/Share
6.50
Total Debt/Equity
N/A
Revenue/Share
6.19 USD as % of share price
Fundamentals
RARE
Capitalization
3.37B
P/E Ratio
N/A
Risk (Beta)
0.04
Dividend Yield
N/A
Total Cash
610M
Total Cash/Share
6.50
Total Debt
40.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.19%
Revenue
560M
ROE
N/A
Book Value
255M
P/B Ratio
13.21
Cash Flow
N/A
Earnings
-6.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
92K
Current Ratio
2.37
Current Revenue Per Employee
127416.54
Dividends Per Share - Security
N/A
EBITDA
-469M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.75
Revenue To Assets
-38.02
Shares Held By Institutions
11B
Shares Outstanding - Current
93.9M
Total Liabilities
1.24B
Total Volume MTD
N/A
Value
-1
Gain YTD
-11.314
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for rare diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com